PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Modena and Reggio Emilia, Modena; Clinical and Experimental Medicine PhD program, University of Modena and Reggio Emilia, Modena; and Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'University of Modena and Reggio Emilia, Modena, and Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'University of Modena and Reggio Emilia, Modena; Clinical and Experimental Medicine PhD program, University of Modena and Reggio Emilia, Modena; and Radiology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Epidemiology Service, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Radiology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'University of Modena and Reggio Emilia, Modena, Italy.\', \'Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Pneumology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'High Intensity Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Immuno-Ophthalmology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Internal Medicine Unit, Guastalla Hospital, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Intensive Care Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Department of Medicine and Surgery, University of Parma, Italy.\', \'University of Modena and Reggio Emilia, Modena, and Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy. salvarani.carlo@ausl.re.it.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Clinical and experimental rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 33275095
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 85
is ?:relation_isRelatedTo_publication of
?:title
  • Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33275095>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33275095>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all